After Adverse Effects, Roche Ends Trials of Diabetes Drug
Patients reported a high rate of adverse reactions in trials for the experimental drug, which the company had hoped would bring in $2 billion a year. feeds.nytimes.com |
Number of fat people in US to grow, report says
By GREG KELLER 2010-09-23T20:49:04ZPARIS (AP) -- Citizens of the world's richest countries are getting fatter and fatter and the United States is leading the charge, an organization of leading economies said Thursday in its first ever obesity forecast.... hosted.ap.org |
Sanofi-Aventis launches Genzyme takeover battle
By GREG KELLER and LINDA A. JOHNSON 2010-10-04T15:56:52ZPARIS (AP) -- France's Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover attempt for Genzyme Corp., escalating the battle after management of the U.S. biotech company twice rejected its offer.... hosted.ap.org |
Electronic patient record 'must be easier for patients to opt out of'
The controversial electronic patient record must become easier to opt out of, a government review has concluded, after a public outcry about confidential information being uploaded without people's knowledge. telegraph.co.uk |
Renewed pressure on WA over health deal
The Federal Health Minister Nicola Roxon says Western Australia should sign up to the Federal Government's hospital funding overhaul if it wants to improve emergency department waiting times. abc.net.au |